Dr. Cushion has recently succeeded in establishing an axenic culture system which supports limited growth of Pc, similar to that achieved with tissue cultures. It is the overall goal of this project to axenically culture Pc. The first specific aim is to attempt to identify isolation procedures that produce the healthiest organisms for culture. To expedite culture development, the investigator also plans to develop rapid methods for evaluation of organism numbers and viability. These methods will then be applied to accomplish the second goal, to axenically culture Pc. The investigator will attempt to develop a medium which supports the growth of Pc by following nutritional evaluations and biochemical analyses used by other investigators who have successfully established such cultures for other protists. Various concentrations of blocks of nutrients commonly required for culture of microbes will be evaluated for Pc growth in the present axenic medium or an improved crude medium. Optimal concentrations of each block will be identified by narrowing the range of dilutions. Once identified, the optimal concentration of a block will remain constant while another block is tested and optimized. Growth and viability will be assessed by a variety of methods including radiolabeled precursor incorporation, enumeration of organisms and fluorometric assay. The third goal of the project is to try to characterize the life cycle stages and kinetics of growth in axenic culture. Ultrastructural and kinetic analyses will be used to identify the life cycle stages replicating in cultures, determine the growth rate, and monitor the health of the organisms. Since parasitic protists commonly decrease their virulence when cultured over long periods and this virulence has oftentimes been linked to surface antigens, the antigenicity of the cultured organisms will be ultrastructurally evaluated. The projects have been designed to provide, first, new or improved methods of assessing organism number and viability. Secondly, it is anticipated that information on the physiologic state of organisms isolated from infected lungs will be obtained. Lastly, it is hoped that increased understanding of the metabolic capabilities of Pc and, in addition, the development of axenic culture for Pc, will be obtained.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI032436-03
Application #
2067325
Study Section
AIDS and Related Research Study Section 3 (ARRC)
Project Start
1992-02-01
Project End
1996-01-31
Budget Start
1994-02-01
Budget End
1996-01-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Icenhour, Crystal R; Arnold, Jonathan; Medvedovic, Mario et al. (2006) Competitive coexistence of two Pneumocystis species. Infect Genet Evol 6:177-86
Icenhour, Crystal R; Rebholz, Sandra L; Collins, Margaret S et al. (2002) Early acquisition of Pneumocystis carinii in neonatal rats as evidenced by PCR and oral swabs. Eukaryot Cell 1:414-9
Icenhour, C R; Cushion, M T (2001) Putative transmissive form of Pneumocystis carinii f. sp. carinii. J Eukaryot Microbiol Suppl:139S-140S
Icenhour, C R; Rebholz, S L; Collins, M S et al. (2001) Early acquisition of Pneumocystis carinii in neonatal rats using targeted PCR and oral swabs. J Eukaryot Microbiol Suppl:135S-136S
Icenhour, C R; Rebholz, S L; Collins, M S et al. (2001) Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs. J Clin Microbiol 39:3437-41
Kaneshiro, E S; Collins, M S; Cushion, M T (2000) Inhibitors of sterol biosynthesis and amphotericin B reduce the viability of pneumocystis carinii f. sp. carinii. Antimicrob Agents Chemother 44:1630-8
Cushion, M T; Linke, M J; Collins, M et al. (1999) The minimum number of Pneumocystis carinii f. sp. carinii organisms required to establish infections is very low. J Eukaryot Microbiol 46:111S
Kaneshiro, E S; Collins, M; Cushion, M T (1999) Effects of sterol inhibitors on the ATP content of Pneumocystis carinii. J Eukaryot Microbiol 46:142S-143S
Icenhour, C R; Arnold, J; Cushion, M T (1999) Interactions of two Pneumocystis carinii populations within rat lungs. J Eukaryot Microbiol 46:107S-108S
Cushion, M T; Chen, F; Kloepfer, N (1997) A cytotoxicity assay for evaluation of candidate anti-Pneumocystis carinii agents. Antimicrob Agents Chemother 41:379-84

Showing the most recent 10 out of 15 publications